| Secondary |
| Drug Use For Unknown Indication |
35.7% |
| Product Used For Unknown Indication |
19.0% |
| Hypertension |
13.1% |
| Congestive Cardiomyopathy |
6.6% |
| Dyslipidaemia |
2.9% |
| Type 2 Diabetes Mellitus |
2.6% |
| Benign Prostatic Hyperplasia |
2.3% |
| Insomnia |
2.2% |
| Essential Hypertension |
2.0% |
| Schizophrenia, Paranoid Type |
2.0% |
| Anxiety |
1.4% |
| Atrial Fibrillation |
1.3% |
| Breast Cancer |
1.3% |
| Bronchitis |
1.3% |
| Cardiovascular Event Prophylaxis |
1.3% |
| Depression |
1.3% |
| Pain |
1.2% |
| Arrhythmia |
0.9% |
| Cardiac Disorder |
0.9% |
| Neuralgia |
0.9% |
|
| Vomiting |
9.8% |
| Electrocardiogram Qt Prolonged |
8.9% |
| Thrombocytopenia |
8.9% |
| Hyperhidrosis |
8.0% |
| Renal Failure |
7.1% |
| Toxic Skin Eruption |
5.4% |
| Visual Acuity Reduced |
5.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.5% |
| Fall |
4.5% |
| Hallucination |
3.6% |
| Hyperkalaemia |
3.6% |
| Malaise |
3.6% |
| Orthostatic Hypotension |
3.6% |
| Pruritus |
3.6% |
| Renal Failure Acute |
3.6% |
| Supraventricular Tachycardia |
3.6% |
| Thrombocytopenic Purpura |
3.6% |
| Vertigo |
3.6% |
| Anaemia Haemolytic Autoimmune |
2.7% |
| Cytolytic Hepatitis |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.9% |
| Product Used For Unknown Indication |
16.7% |
| Hypertension |
14.9% |
| Prophylaxis |
5.3% |
| Pain |
4.1% |
| Depression |
3.7% |
| Cardiac Disorder |
3.6% |
| Diabetes Mellitus |
3.2% |
| Vertigo |
3.1% |
| Osteoporosis |
2.9% |
| Unevaluable Event |
2.8% |
| Hypercholesterolaemia |
2.4% |
| Anxiety |
2.3% |
| Type 2 Diabetes Mellitus |
2.0% |
| Bronchitis |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Arrhythmia |
1.7% |
| Coronary Artery Disease |
1.6% |
| Atrial Fibrillation |
1.5% |
| Multiple Myeloma |
1.4% |
|
| Vomiting |
11.7% |
| Hyponatraemia |
8.5% |
| Renal Failure Acute |
8.2% |
| Renal Failure |
7.0% |
| Thrombocytopenia |
6.7% |
| Pyrexia |
6.1% |
| Weight Decreased |
5.3% |
| Pancreatitis |
5.0% |
| Toxic Skin Eruption |
4.7% |
| Fall |
3.8% |
| Orthostatic Hypotension |
3.8% |
| Vertigo |
3.8% |
| Myalgia |
3.5% |
| Myocardial Infarction |
3.5% |
| Somnolence |
3.5% |
| Lung Disorder |
3.2% |
| Weight Increased |
3.2% |
| Melaena |
2.9% |
| Urinary Retention |
2.9% |
| Death |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
92.0% |
| Hypertension |
8.0% |
|
| Thoracic Vertebral Fracture |
25.0% |
| Traumatic Brain Injury |
25.0% |
| Fall |
12.5% |
| Haemarthrosis |
12.5% |
| Orthostatic Hypotension |
12.5% |
| Osteoarthritis |
12.5% |
|
